Evidence map›Paper›PMID 31316342›Full record

ArticleFrontiers in neuroscience2019

PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts.

Giuseppina Amodio, Ornella Moltedo, Dominga Fasano, Lucrezia Zerillo, Marco Oliveti, Paola Di Pietro, Raffaella Faraonio, Paolo Barone, Maria Teresa Pellecchia, Anna De Rosa and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Camboginol and Morelloflavone fromPreventive nutrition and food science · 2022
    Article
  13. New Frontiers on ER Stress Modulation: Are TRP Channels the Leading Actors?International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Giuseppina AmodioDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
Ornella MoltedoDepartment of Pharmacy, University of Salerno, Salerno, Italy.
Dominga FasanoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Lucrezia ZerilloDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Marco OlivetiDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
Paola Di PietroDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
Raffaella FaraonioDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Paolo BaroneSection of Neuroscience, Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Maria Teresa PellecchiaSection of Neuroscience, Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Anna De RosaDepartment of Neuroscience, Reproductive, and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Giuseppe De MicheleDepartment of Neuroscience, Reproductive, and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Elena PolishchukTelethon Institute of Genetics and Medicine, Pozzuoli, Italy.
Roman PolishchukTelethon Institute of Genetics and Medicine, Pozzuoli, Italy.
Vincenzo BonifatiDepartment of Clinical Genetics, Erasmus MC, Rotterdam, Netherlands.
Lucio NitschDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Giovanna Maria PierantoniDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Maurizio RennaDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Chiara CriscuoloDepartment of Neuroscience, Reproductive, and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Simona PaladinoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Paolo RemondelliDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
University of Naples Federico II · ITUniversity of Salerno · ITTelethon Institute Of Genetics And Medicine · ITErasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PARK20, an early onset autosomal recessive parkinsonism is due to mutations in the phosphatidylinositol-phosphatase Synaptojanin 1 (Synj1). We have recently shown that the early endosomal compartments are profoundly altered in PARK20 fibroblasts as well as the endosomal trafficking. Here, we report that PARK20 fibroblasts also display a drastic alteration of the architecture and function of the early secretory compartments. Our results show that the exit machinery from the Endoplasmic Reticulum (ER) and the ER-to-Golgi trafficking are markedly compromised in patient cells. As a consequence, PARK20 fibroblasts accumulate large amounts of cargo proteins within the ER, leading to the induction of ER stress. Interestingly, this stressful state is coupled to the activation of the PERK/eIF2α/ATF4/CHOP pathway of the Unfolded Protein Response (UPR). In addition, PARK20 fibroblasts reveal upregulation of oxidative stress markers and total ROS production with concomitant alteration of the morphology of the mitochondrial network. Interestingly, treatment of PARK20 cells with GSK2606414 (GSK), a specific inhibitor of PERK activity, restores the level of ROS, signaling a direct correlation between ER stress and the induction of oxidative stress in the PARK20 cells. All together, these findings suggest that dysfunction of early secretory pathway might contribute to the pathogenesis of the disease.

Indexed as

ER stressmembrane traffickingmitochondrial dysfunctionoxydative stressPARK20Parkinson’s diseasePERK (PKR-like endoplasmic reticulum kinase)Synaptojanin 1

Identifiers

PMID31316342
PMCPMC6610533
OpenAlexW2949618092

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.